Page 47 - Adherence News Today

Philips announced the main terms of an agreement it reached in January with the U.S. government on its new sleep apnea machines, which has already cost the company over 360...

A mandibular advancement device was non-inferior to standard of care CPAP to reduce blood pressure in patients with hypertension and sleep apnea in the CRESCENT trial.

A mobile application improved erectile function during a 12-week trial, researchers report.

The US Food and Drug Administration has approved the first-ever prescription app for major depressive disorder.

AI tool DrugGPT offers instant second opinions for clinicians and empowers patients with comprehensive medication information.

Erenumab was more effective than oral preventive medications in reducing migraine days with better patient adherence and satisfaction.

The warning applies to unapproved products illegally marketed for topical use to relieve pain before, during, or after cosmetic procedures.

Experts review comprehensive strategies to enhance patient safety and responsible opioid management across assessment, monitoring, alternatives, and collaboration.

The results of a new study support the use of delayed hysterectomy and conservative management as safe alternatives to cesarean hysterectomy.

A panel of experts analyze the impact of prefilled syringes on workflows across diverse patient populations, emphasizing cost savings, patient safety, and interdisciplinary collaboration.